Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02067286 · ClinicalTrials.gov registry record

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

A clinical trial of Respiratory Syncytial Virus (RSV) and Influenza a, sponsored by IQuum.

Completed
Registry status
1,642
Enrollment target
8
Study locations

NCT02067286 is a study of Respiratory Syncytial Virus (RSV) and Influenza a that has completed, run by IQuum. The registered enrollment target is 1,642 participants, below the 6,607-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (75% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02067286, a study of Respiratory Syncytial Virus (RSV) and Influenza a, has completed, sponsored by IQuum.

COMPLETED
Registry status
1,642 participants
Enrollment target
8
Study locations

Study Summary

The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.

Conditions Studied

Respiratory Syncytial Virus (RSV) Influenza a Influenza B

Study Locations (8)

Texas

  • Accurate Clinical Research - Houston
  • Plano Pediatrics - Plano

Florida

  • Pediatrics-by-the-Sea - Delray Beach

Georgia

  • Meridian Clinical Research - Savannah

Indiana

  • Northpoint Pediatrics - Indianapolis

Nebraska

  • Meridian Clinical Research - Bellevue

Ohio

  • Cleveland Clinic - Cleveland

Virginia

  • Advanced Pediatrics - Vienna

Trial Details

FieldValue
Enrollment Target 1,642 participants
Start Date 2014-01
Est. Completion 2015-04

Sponsor

IQuum

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02067286

The ClinicalTrials.gov registry entry for NCT02067286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,642 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,607-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (75% lower). The listed sponsor is IQuum, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Respiratory Syncytial Virus (RSV) appearing as the primary indexed condition, and to 0 interventions.

NCT02067286 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Texas, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT02067286 about?

NCT02067286 is a clinical study titled "Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer". The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as com...

What is the current status of trial NCT02067286?

This trial is currently completed. The enrollment target is 1,642 participants. The study started on 2014-01. Estimated completion is 2015-04.

What conditions does trial NCT02067286 study?

This clinical trial studies the following conditions: Respiratory Syncytial Virus (RSV), Influenza a, Influenza B.

Who is sponsoring clinical trial NCT02067286?

This trial is sponsored by IQuum, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02067286 being conducted?

This trial has 8 study locations across Florida, Georgia, Indiana, Nebraska, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Respiratory Syncytial Virus (RSV)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Respiratory Syncytial Virus (RSV)

All registered trials for this condition

Influenza a

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.